Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN
Bromodomain and extra-terminal domain (BET) family proteins play important roles in regulating the expression of multiple proto-oncogenes by recognizing acetylation of histones and non-histone proteins including transcription factors, which subsequently promote tumor cell proliferation, survival, me...
Main Authors: | Xiyao Shi, Ying Wang, Longhui Zhang, Wenjie Zhao, Xiangpeng Dai, Yong-Guang Yang, Xiaoling Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1021820/full |
Similar Items
-
Epigenetic Dysregulation in <i>MYCN</i>-Amplified Neuroblastoma
by: Soraya Epp, et al.
Published: (2023-12-01) -
The potential molecularly therapy target to MYCN‐amplificated neuroblastoma
by: Susu Jiang, et al.
Published: (2023-08-01) -
Metastasis in neuroblastoma: the MYCN question
by: Swapnil Parashram Bhavsar
Published: (2023-05-01) -
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
by: Kezhe Tan, et al.
Published: (2022-12-01) -
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
by: Anders Valind, et al.
Published: (2023-12-01)